Eli Lilly ends antibody study after hospitalized COVID-19 patients show little gain by socialtern | Oct 27, 2020 | General News | 0 comments Indianapolis-based Eli Lilly and Co. gives an update on third-quarter earnings. Source Submit a Comment Cancel replyYou must be logged in to post a comment.
Recent Comments